CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma
CRISPR筛选发现ATPase VCP是胆管癌中一个可药物靶向的治疗弱点
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2519568122
Yang, Wu; Wang, Siying; Ji, Shuyi; Wang, Jian; Lian, Shuo; Li, Zhe; Jansen, Robin A; Wu, Wei; Niu, Kongyan; Sun, Zhen; Jia, Qi; Zheng, Jiaojiao; Zhu, Huijue; Deng, Xuan; Wang, Liqin; Fan, Zhoulong; Shi, Yaoping; Lieftink, Cor; Guan, Ming; Beijersbergen, Roderick L; Qin, Wenxin; Gao, Qiang; Bernards, René; Jin, Haojie
